|
1
|
Chareonthaitawee P, Gersh BJ, Araoz PA and
Gibbons RJ: Revascularization in severe left ventricular
dysfunction: The role of viability testing. J Am Coll Cardiol.
46:567–574. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Karantalis V, Suncion-Loescher VY, Bagno
L, Golpanian S, Wolf A, Sanina C, Premer C, Kanelidis AJ, McCall F,
Wang B, et al: Synergistic Effects of combined cell therapy for
chronic ischemic cardiomyopathy. J Am Coll Cardiol. 66:1990–1999.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Natsumeda M, Florea V, Rieger AC, Tompkins
BA, Banerjee MN, Golpanian S, Fritsch J, Landin AM, Kashikar ND,
Karantalis V, et al: A combination of allogeneic stem cells
promotes cardiac regeneration. J Am Coll Cardiol. 70:2504–2515.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Abdelwahid E, Kalvelyte A, Stulpinas A, de
Carvalho KA, Guarita-Souza LC and Foldes G: Stem cell death and
survival in heart regeneration and repair. Apoptosis. 21:252–268.
2016. View Article : Google Scholar
|
|
5
|
Golpanian S, Wolf A, Hatzistergos KE and
Hare JM: Rebuilding the damaged heart: Mesenchymal stem cells,
cell-based therapy, and engineered heart tissue. Physiol Rev.
96:1127–1168. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Luedike P, Hendgen-Cotta UB, Sobierajski
J, Totzeck M, Reeh M, Dewor M, Lue H, Krisp C, Wolters D, Kelm M,
et al: Cardioprotection through S-nitros(yl)ation of macrophage
migration inhibitory factor. Circulation. 125:1880–1889. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Calandra T and Roger T: Macrophage
migration inhibitory factor: A regulator of innate immunity. Nat
Rev Immunol. 3:791–800. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Qi D, Hu X, Wu X, Merk M, Leng L, Bucala R
and Young LH: Cardiac macrophage migration inhibitory factor
inhibits JNK pathway activation and injury during
ischemia/reperfusion. J Clin Invest. 119:3807–3816. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zernecke A, Bernhagen J and Weber C:
Macrophage migration inhibitory factor in cardiovascular disease.
Circulation. 117:1594–1602. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sun Q, Hao Q and Prasanth KV: Nuclear long
noncoding RNAs: Key regulators of gene expression. Trends Genet.
S0168-9525(17)30207-X. 2017.PubMed/NCBI
|
|
11
|
Liu C, Yang Z, Wu J, Zhang L, Lee S, Shin
DJ, Tran M and Wang L: Long noncoding RNA H19 interacts with
polypyrimidine tract-binding protein 1 to reprogram hepatic lipid
homeostasis. Hepatology. 67:1768–1783. 2018. View Article : Google Scholar
|
|
12
|
Chew CL, Conos SA, Unal B and Tergaonkar
V: Noncoding RNAs: Master regulators of inflammatory signaling.
Trends Mol Med. 24:66–84. 2018. View Article : Google Scholar
|
|
13
|
Bao X, Wu H, Zhu X, Guo X, Hutchins AP,
Luo Z, Song H, Chen Y, Lai K, Yin M, et al: The p53-induced
lincRNA-p21 derails somatic cell reprogramming by sustaining
H3K9me3 and CpG methylation at pluripotency gene promoters. Cell
Res. 25:80–92. 2015. View Article : Google Scholar :
|
|
14
|
Yang N, Fu Y, Zhang H, Sima H, Zhu N and
Yang G: LincRNA-p21 activates endoplasmic reticulum stress and
inhibits hepatocellular carcinoma. Oncotarget. 6:28151–28163.
2015.PubMed/NCBI
|
|
15
|
Yang W, Yu H, Shen Y, Liu Y, Yang Z and
Sun T: MiR-146b-5p overexpression attenuates stemness and
radioresistance of glioma stem cells by targeting
HuR/lincRNA-p21/β-catenin pathway. Oncotarget. 7:41505–41526.
2016.PubMed/NCBI
|
|
16
|
Xia W, Zhuang L, Deng X and Hou M: Long
noncoding RNA-p21 modulates cellular senescence via the
Wnt/β-catenin signaling pathway in mesenchymal stem cells. Mol Med
Rep. 16:7039–7047. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yoshihisa Y, Rehman MU, Kondo T and
Shimizu T: Role of macrophage migration inhibitory factor in
heat-induced apoptosis in keratinocytes. Faseb J. 30:3870–3877.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gammons M and Bienz M: Multiprotein
complexes governing Wnt signal transduction. Curr Opin Cell Biol.
51:42–49. 2018. View Article : Google Scholar
|
|
19
|
Yoon JH, Abdelmohsen K, Srikantan S, Yang
X, Martindale JL, De S, Huarte M, Zhan M, Becker KG and Gorospe M:
LincRNA-p21 suppresses target mRNA translation. Mol Cell.
47:648–655. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yu F, Guo Y, Chen B, Shi L, Dong P, Zhou M
and Zheng J: LincRNA-p21 inhibits the Wnt/β-catenin pathway in
activated hepatic stellate cells via sponging MicroRNA-17-5p. Cell
Physiol Biochem. 41:1970–1980. 2017. View Article : Google Scholar
|
|
21
|
Zhu W, Chen J, Cong X, Hu S and Chen X:
Hypoxia and serum deprivation-induced apoptosis in mesenchymal stem
cells. Stem Cells. 24:416–425. 2006. View Article : Google Scholar
|
|
22
|
Gore Y, Starlets D, Maharshak N,
Becker-Herman S, Kaneyuki U, Leng L, Bucala R and Shachar I:
Macrophage migration inhibitory factor induces B cell survival by
activation of a CD74-CD44 receptor complex. J Biol Chem.
283:2784–2792. 2008. View Article : Google Scholar
|
|
23
|
Liu Y, Xiong Y, Xing F, Gao H, Wang X, He
L, Ren C, Liu L, So KF and Xiao J: Precise regulation of miR-210 is
critical for the cellular homeostasis maintenance and
transplantation efficacy enhancement of mesenchymal stem cells in
acute liver failure therapy. Cell Transplant. 26:805–820. 2017.
View Article : Google Scholar :
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
25
|
Xia W, Xie C, Jiang M and Hou M: Improved
survival of mesen-chymal stem cells by macrophage migration
inhibitory factor. Mol Cell Biochem. 404:11–24. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Shen Y, Liu Y, Sun T and Yang W:
LincRNA-p21 knockdown enhances radiosensitivity of hypoxic tumor
cells by reducing autophagy through HIF-1/Akt/mTOR/P70S6K pathway.
Exp Cell Res. 358:188–198. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Maj T, Wang W, Crespo J, Zhang H, Wang W,
Wei S, Zhao L, Vatan L, Shao I, Szeliga W, et al: Oxidative stress
controls regulatory T cell apoptosis and suppressor activity and
PD-L1-blockade resistance in tumor. Nat Immunol. 18:1332–1341.
2017. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Nakamura Y, Wang X, Xu C, Asakura A,
Yoshiyama M, From AH and Zhang J: Xenotransplantation of
long-term-cultured swine bone marrow-derived mesenchymal stem
cells. Stem Cells. 25:612–620. 2007. View Article : Google Scholar
|
|
29
|
Amado LC, Schuleri KH, Saliaris AP, Boyle
AJ, Helm R, Oskouei B, Centola M, Eneboe V, Young R, Lima JA, et
al: Multimodality noninvasive imaging demonstrates in vivo cardiac
regeneration after mesenchymal stem cell therapy. J Am Coll
Cardiol. 48:2116–2124. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hare JM, Traverse JH, Henry TD, Dib N,
Strumpf RK, Schulman SP, Gerstenblith G, DeMaria AN, Denktas AE,
Gammon RS, et al: A randomized, double-blind, placebo-controlled,
dose-escalation study of intravenous adult human mesenchymal stem
cells (prochymal) after acute myocardial infarction. J Am Coll
Cardiol. 54:2277–2286. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ye L, Zhang P, Duval S, Su L, Xiong Q and
Zhang J: Thymosin β4 increases the potency of transplanted
mesenchymal stem cells for myocardial repair. Circulation. 128(11
Suppl 1): S32–S41. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Takahashi M, Nishihira J, Katsuki T,
Kobayashi E, Ikeda U and Shimada K: Elevation of plasma levels of
macrophage migration inhibitory factor in patients with acute
myocardial infarction. Am J Cardiol. 89:248–249. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yu CM, Lai KW, Chen YX, Huang XR and Lan
HY: Expression of macrophage migration inhibitory factor in acute
ischemic myocardial injury. J Histochem Cytochem. 51:625–631. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chagnon F, Metz CN, Bucala R and Lesur O:
Endotoxin-induced myocardial dysfunction: Effects of macrophage
migration inhibitory factor neutralization. Circ Res. 96:1095–1102.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wang J, Tong C, Yan X, Yeung E, Gandavadi
S, Hare AA, Du X, Chen Y, Xiong H, Ma C, et al: Limiting cardiac
ischemic injury by pharmacological augmentation of macrophage
migration inhibitory factor-AMP-activated protein kinase signal
transduction. Circulation. 128:225–236. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ulitsky I and Bartel DP: lincRNAs:
Genomics, evolution, and mechanisms. Cell. 154:26–46. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Schmitt AM, Garcia JT, Hung T, Flynn RA,
Shen Y, Qu K, Payumo AY, Peres-da-Silva A, Broz DK, Baum R, et al:
An inducible long noncoding RNA amplifies DNA damage signaling. Nat
Genet. 48:1370–1376. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Liu X, Xiao ZD, Zhang J, Lee SW, Wang W,
Lee H, Zhuang L, Chen J and Lin HK: LncRNA NBR2 engages a metabolic
checkpoint by regulating AMPK under energy stress. Nat Cell Biol.
18:431–442. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Chen S, Liang H, Yang H, Zhou K, Xu L, Liu
J, Lai B, Song L, Luo H, Peng J, et al: LincRNa-p21: Function and
mechanism in cancer. Med Oncol. 34:982017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Lettini G, Sisinni L, Condelli V, Matassa
DS, Simeon V, Maddalena F, Gemei M, Lopes E, Vita G, Del Vecchio L,
et al: TRAP1 regulates stemness through Wnt/β-catenin pathway in
human colorectal carcinoma. Cell Death Differ. 23:1792–1803. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wang J, Lei ZJ, Guo Y, Wang T, Qin ZY,
Xiao HL, Fan LL, Chen DF, Bian XW, Liu J and Wang B:
miRNA-regulated delivery of lincRNA-p21 suppresses β-catenin
signaling and tumorigenicity of colorectal cancer stem cells.
Oncotarget. 6:37852–37870. 2015.PubMed/NCBI
|
|
42
|
Zhang X, Chen L, Wang Y, Ding Y, Peng Z,
Duan L, Ju G, Ren Y and Wang X: Macrophage migration inhibitory
factor promotes proliferation and neuronal differentiation of
neural stem/precursor cells through Wnt/β-catenin signal pathway.
Int J Biol Sci. 9:1108–1120. 2013. View Article : Google Scholar :
|
|
43
|
Matsushima S, Kuroda J, Zhai P, Liu T,
Ikeda S, Nagarajan N, Oka S, Yokota T, Kinugawa S, Hsu CP, et al:
Tyrosine kinase FYN negatively regulates NOX4 in cardiac
remodeling. J Clin Invest. 126:3403–3416. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Han YS, Lee JH, Jung JS, Noh H, Baek MJ,
Ryu JM, Yoon YM, Han HJ and Lee SH: Fucoidan protects mesenchymal
stem cells against oxidative stress and enhances vascular
regeneration in a murine hindlimb ischemia model. Int J Cardiol.
198:187–195. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zhang D, Lee H, Haspel JA and Jin Y: Long
noncoding RNA FOXD3-AS1 regulates oxidative stress-induced
apoptosis via sponging microRNA-150. FASEB J. 31:4472–4481. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Xu X, Bucala R and Ren J: Macrophage
migration inhibitory factor deficiency augments doxorubicin-induced
cardiomyopathy. J Am Heart Assoc. 2:e0004392013. View Article : Google Scholar : PubMed/NCBI
|
